A Phase II Clinical Trial of the Safety and Efficacy of SAL0120 in Patients With Chronic Kidney Disease (CKD)

Clinical trial NCT07716618 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07716618
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2025-01-17
Primary completion: 2026-05-27
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.